Editorial Commentary
Checkpoint inhibitors first in patients with metastatic non-small cell lung cancer harboring BRAFV600E mutation with PD-L1 90%—a debate in a niche population
Precision Cancer Medicine
2020;
3:
35
(30 December 2020)
Editorial Commentary
CM227/CM9-LA: evidence supporting ipilimumab-based immunotherapy in the first-line treatment of metastatic NSCLC
Precision Cancer Medicine
2020;
3:
34
(30 December 2020)
Editorial Commentary
Pembrolizumab monotherapy in the first-line treatment of EGFR/ALK wildtype, PD-L1 tumor proportion score (TPS) 1–49%, advanced non-small cell lung cancer (NSCLC): con: “It takes two to tango”
Precision Cancer Medicine
2020;
3:
33
(30 December 2020)
Editorial Commentary
ADAURA: a definitive answer to the wrong question
Precision Cancer Medicine
2020;
3:
32
(30 December 2020)
Letter to the Editor
Utility of high-throughput sequencing of T-cell receptor rearrangements in assessing treatment response in patients with mature T-cell lymphoma
Precision Cancer Medicine
2020;
3:
31
(30 December 2020)
Case Report
Use of 3D-planning and tantalum in revision total hip arthroplasty after failed iliac bone allograft for Ewing sarcoma: a case report
Precision Cancer Medicine
2020;
3:
30
(30 December 2020)
Case Report
Effective tyrosine kinase inhibitor re-treatment in epidermal growth factor receptor-mutated non-small-cell lung cancer patient: a case report
Precision Cancer Medicine
2020;
3:
29
(30 December 2020)
Case Report
Feasibility of ultra-central stereotactic ablative irradiation in lung cancer undergoing nivolumab: a case report
Precision Cancer Medicine
2020;
3:
28
(30 December 2020)
Case Report
Micrometastatic breast cancer presenting as abnormal uterine bleeding: case report
Precision Cancer Medicine
2020;
3:
27
(30 December 2020)
Review Article
A narrative review of BRAF alterations in human tumors: diagnostic and predictive implications
Precision Cancer Medicine
2020;
3:
26
(30 December 2020)
Review Article
Central nervous system progression and liquid biopsy in patients with oncogene addicted non-small cell lung cancer treated with ALK/ROS1 inhibitors
Precision Cancer Medicine
2020;
3:
25
(30 December 2020)
Case Report
“Lazarus effect” in patient affected by lung adenocarcinoma carrying EGFR, CTNNB1, MET exon 11 and PIK3CA mutations treated with gefitinib
Precision Cancer Medicine
2020;
3:
23
(30 September 2020)
Case Report: Precision Oncology Tumor Board
Prolonged immune checkpoint inhibitor response of a patient with a RET rearranged non-small cell lung cancer and high tumour mutational burden: case report and review of the literature
Precision Cancer Medicine
2020;
3:
22
(30 September 2020)
Case Report: Precision Oncology Tumor Board
Trastuzumab-Pertuzumab resistance in a case of HER2-del16 expressing colorectal cancer—a case report
Precision Cancer Medicine
2020;
3:
21
(30 September 2020)
Review Article
A narrative review of salvage therapy in small cell lung cancer
Precision Cancer Medicine
2020;
3:
20
(30 September 2020)
Review Article
Prognostic impact of targetable genetic variants in resected adenocarcinoma of the lung: a narrative review and model proposal for precise evaluation
Precision Cancer Medicine
2020;
3:
19
(30 September 2020)
Editorial Commentary
Current and future perspectives in lung cancer prevention
Precision Cancer Medicine
2020;
3:
18
(30 September 2020)
Case Report: Precision Oncology Tumor Board
Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Precision Cancer Medicine
2020;
3:
17
(15 June 2020)
Case Report
Hepatic lymphoepithelioma-like carcinoma: a case report with literature review
Precision Cancer Medicine
2020;
3:
16
(15 June 2020)
Review Article
Nutrition, disease and underlying molecular mechanisms
Precision Cancer Medicine
2020;
3:
15
(15 June 2020)
Review Article
NTRK and NRG1 gene fusions in advanced non-small cell lung cancer (NSCLC)
Precision Cancer Medicine
2020;
3:
14
(15 June 2020)
Original Article
Digging deep or spreading wide?—a comparison of polymerase chain reaction and sequencing approaches in the analysis of circulating tumor DNA
Precision Cancer Medicine
2020;
3:
13
(15 June 2020)
Original Article
Factors associated with the extent of resection of glioblastoma
Precision Cancer Medicine
2020;
3:
12
(15 June 2020)
Editorial Commentary
Cancer immunotherapy: lessons from the parasites to improve fighting against tumors
Precision Cancer Medicine
2020;
3:
11
(15 June 2020)
Case Report: Precision Oncology Tumor Board
Exploiting homologous recombination repair alterations in metastatic castrate-resistant prostate cancer: a case report and literature review
Precision Cancer Medicine
2020;
3:
10
(15 March 2020)
Case Report: Precision Oncology Tumor Board
Utilizing genomic profiling in a patient with a thoracic malignancy of uncertain primary: case report
Precision Cancer Medicine
2020;
3:
9
(15 March 2020)
Case Report: Precision Oncology Tumor Board
Targeting EGFR mutations needs to be more precise with co-mutations
Precision Cancer Medicine
2020;
3:
8
(15 March 2020)
Review Article
Non-small cell lung cancer PDL1 >50%—should we go single or combo?
Precision Cancer Medicine
2020;
3:
7
(15 March 2020)
Review Article
Annotating the next generation sequencing report
Precision Cancer Medicine
2020;
3:
6
(15 March 2020)
Review Article
Non-small cell lung cancer targetable mutations: present and future
Precision Cancer Medicine
2020;
3:
5
(15 March 2020)
Review Article
Circulating tumor cells: moving forward into clinical applications
Precision Cancer Medicine
2020;
3:
4
(15 March 2020)
Original Article
Significance of alectinib in anaplastic lymphoma kinase-tyrosine kinase inhibitors for anaplastic lymphoma kinase-positive patients with non–small cell lung cancer
Precision Cancer Medicine
2020;
3:
3
(15 March 2020)
Editorial
Sharing data: a requirement for expanding precision oncology
Precision Cancer Medicine
2020;
3:
2
(15 March 2020)
Editorial
The current and future revolution in lung cancer screening and management
Precision Cancer Medicine
2020;
3:
1
(15 March 2020)
Editorial Commentary
Immunotherapy approaches to beat tumors
Precision Cancer Medicine
2019;
2:
38
(26 December 2019)
Review Article
Predictive and prognostic implications of microsatellite instability and mismatch repair deficiency in carcinomas of the gastrointestinal tract, liver, and pancreas
Precision Cancer Medicine
2019;
2:
36
(12 December 2019)
Review Article
How to recognize and manage hyper-progression and pseudo-progression during immune checkpoint blockade in non-small cell lung cancer
Precision Cancer Medicine
2019;
2:
35
(12 December 2019)
Review Article
Lung cancer screening: where do we stand?
Precision Cancer Medicine
2019;
2:
34
(12 December 2019)
Review Article
Precision medicine and future of cancer treatment
Precision Cancer Medicine
2019;
2:
33
(12 December 2019)
News
Application of the CARE guideline as reporting standard in the Precision Cancer Medicine
Precision Cancer Medicine
2019;
2:
32
(12 December 2019)
Original Article
Differences in optimal timing of post-surgical surveillance for limited stage lung cancer patients and associations with outcomes
Precision Cancer Medicine
2019;
2:
31
(12 December 2019)
Original Article
Data sharing in the era of precision medicine: a scientometric analysis
Precision Cancer Medicine
2019;
2:
30
(12 December 2019)
Review Article: Precision Oncology Tumor Board
Precision medicine: BRAF mutations in thyroid cancer
Precision Cancer Medicine
2019;
2:
29
(22 November 2019)
Review Article: Precision Oncology Tumor Board
Cancer diagnosis after solid organ transplantation: do we need to know the cell of origin?
Precision Cancer Medicine
2019;
2:
28
(22 November 2019)
Review Article: Precision Oncology Tumor Board
Targeting ErbB2 aberrations in non-small cell lung cancer
Precision Cancer Medicine
2019;
2:
27
(22 November 2019)
Review Article
Robotic thoracic surgery, the age of majority
Precision Cancer Medicine
2019;
2:
26
(02 September 2019)
Review Article
Defining precision cellular immunotherapy—seeking biomarkers to predict and optimize outcomes of T cell therapies in cancer
Precision Cancer Medicine
2019;
2:
25
(22 August 2019)